Papillary Lesions of the Breast at Percutaneous Core-Needle Biopsy
Authors:
- Cecilia L. MercadoCMCecilia L. Mercado
- Diane Hamele-BenaDHDiane Hamele-Bena
- Shara M. OkenSOShara M. Oken
- Cory I. SingerCSCory I. Singer
- Joan CangiarellaJCJoan Cangiarella
- 1 March 2006
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 238 (3) , 801-808
Abstract
To retrospectively review the imaging and histologic findings in patients in whom a benign papillary lesion was diagnosed at core-needle breast biopsy. This retrospective study was approved by the institutional review board at each institution; patient consent was not required. The study was HIPAA compliant. The authors reviewed the findings from 42 patients (age range, 26-76 years; mean age, 54.3 years) with 43 benign papillary lesions diagnosed at core-needle biopsy. Thirty-six (84%) of the 43 lesions were surgically excised, and seven (16%) were followed up with long-term imaging. The authors assessed the radiographic findings, the histologic findings at core-needle biopsy, and the findings at subsequent surgical excision or imaging follow-up. Statistical analysis was performed on a per-patient basis and included the Blyth-Still-Casella procedure to construct exact 95% confidence intervals (CIs) and the Fisher exact test. At core-needle biopsy, lesions were diagnosed as papilloma (n = 29), sclerosing papilloma (n = 8), and benign papillary lesions not otherwise specified (n = 6). For the 36 lesions that were surgically excised, histologic follow-up showed no residual lesion in 10, intraductal papilloma in 14, intraductal papillomatosis in two, papilloma with adjacent foci of atypical ductal hyperplasia (ADH) in eight, and well-differentiated papillary ductal carcinoma in situ (DCIS) in two. Mammographic follow-up in the remaining seven lesions revealed stable calcifications in five (at 28-55 months) and no residual lesion in two (at 26-29 months). In nine of the 42 patients (21%), the diagnosis was upgraded to either ADH or DCIS (exact two-sided 95% CI = 11.4%, 36.4%). The results strongly suggest that papillary lesions diagnosed as benign at core-needle biopsy should be surgically excised because a substantial number of lesions were upgraded to ADH and DCIS at excision.Keywords
This publication has 15 references indexed in Scilit:
- Papillomas and Atypical Papillomas in Breast Core Needle Biopsy SpecimensAmerican Journal of Clinical Pathology, 2004
- Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancyLaboratory Investigation, 2004
- Role of Mammography, Ultrasound and Large Core Biopsy in the Diagnostic Evaluation of Papillary Breast LesionsOncology, 2003
- Imaging-Guided Core Needle Biopsy of Papillary Lesions of the BreastAmerican Journal of Roentgenology, 2002
- Surgical and Mammographic Follow-Up of Papillary Lesions and Atypical Lobular Hyperplasia Diagnosed With Stereotactic Vacuum-Assisted BiopsyThe Breast Journal, 2002
- Papillary Lesions of the Breast: Evaluation with Stereotactic Directional Vacuum-assisted BiopsyRadiology, 2001
- Uncommon High-Risk Lesions of the Breast Diagnosed at Stereotactic Core-Needle Biopsy: Clinical ImportanceRadiology, 2000
- Percutaneous large-core biopsy of papillary breast lesions.American Journal of Roentgenology, 1999
- Sclerosing papillary proliferations in the female breast.A benign lesion often mistaken for carcinomaCancer, 1974
- The differential diagnosis of papillary tumors of the breastCancer, 1962